Patterson H, Barnes D, Gill S, Spicer J, Fisher C, Thomas M, Grimer R, Fletcher C, Gusterson B, Cooper C
Section of Molecular Carcinogenesis Institute of Cancer Research Haddow Laboratories 15 Downs Road, Belmont, Sutton Surrey SM2 5NG UK.
Sarcoma. 1997;1(1):17-22. doi: 10.1080/13577149778434.
Purpose. Amplification of genetic sequences on chromosome 12q13 is frequently found in soft tissue tumours. However, for the MDM2 gene, over-expression of the MDM2 protein has not always been shown to accompany gene amplification, raising the possibility that amplification of genetic sequences targets alternative genes on chromosome 12q13 for over-expression. To investigate this discrepancy, we have examined 129 soft tissue tumours for amplification of the MDM2 gene using Southern analysis, and 39 of these tumours were also examined by immunohistochemical staining for MDM2 over-expression.Results. Gene amplification was identified in 14/114 (12.3%) of the malignant tumours, but was not identified in any of the benign tumours; 21/39 (54%) of the malignant tumours also demonstrated MDM2 over-expression. Within this group the MDM2 gene was over-expressed in every tumour in which the gene amplification was found, and over-expression in the absence of gene amplification was also found in an additional 10 tumours.Discussion. These data demonstrate a clear correlation between the presence of MDM2 amplification and MDM2 over-expression, and provide persuasive evidence therefore that the amplification of genetic sequences on chromosome 12q13 in soft tissue sarcomas targets the MDM2 gene for over-expression. These data also indicate that alternative mechanisms may contribute to MDM2 over-expression within some tumours.
目的。12q13染色体上的基因序列扩增在软组织肿瘤中很常见。然而,对于MDM2基因,MDM2蛋白的过表达并不总是与基因扩增相伴出现,这就增加了基因序列扩增靶向12q13染色体上其他基因导致过表达的可能性。为了研究这种差异,我们采用Southern分析检测了129例软组织肿瘤中MDM2基因的扩增情况,其中39例肿瘤还进行了MDM2过表达的免疫组织化学染色。结果。在114例恶性肿瘤中有14例(12.3%)检测到基因扩增,而在任何良性肿瘤中均未检测到;21/39(54%)的恶性肿瘤也显示MDM2过表达。在这组肿瘤中,发现基因扩增的每个肿瘤中MDM2基因均过表达,另外在10个肿瘤中还发现了无基因扩增情况下的过表达。讨论。这些数据表明MDM2扩增与MDM2过表达之间存在明显的相关性,因此提供了有说服力的证据,即软组织肉瘤中12q13染色体上的基因序列扩增靶向MDM2基因导致过表达。这些数据还表明,在某些肿瘤中,其他机制可能导致MDM2过表达。